Delivery Order SPE2DB20D3101-SPE2DB25FRNE8
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,575.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024. The contract has a completion date of November 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,369.35, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a term running through January 23, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, the Corporate Office division of a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for AmerisourceBergen to...
This federal contract award is for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,344.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order has a ceiling value of $1,487.43 and an ultimate completion date of June 6, 2025. The prime contractor for this award is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not set aside and is part of a larger $999,999,999.00...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,641.66 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on July 31, 2024 with an ultimate completion date of August 1, 2024. This contract is not a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,699.35 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 14, 2024, with a completion date of June 17, 2024. This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,480.22 firm fixed-price delivery order is for the XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,629.66 firm fixed-price delivery order is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,247.87 and a completion date of October 31, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...